Asim Maqsood, MD
Sleep Medicine · Oklahoma City, OKNPI 1821137050
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (32.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 53.1% of the total.
Across 62 payments — averaging $115.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$4K
- Jazz Pharmaceuticals Inc.$3K
- Fisher & Paykel Healthcare Inc$289
- Harmony Biosciences LLC$270
- Avadel CNS Pharmaceuticals, LLC$81
- AbbVie$48
- plus $140 from 5 others
What the payments were for
- Consulting fees$2,25031%
- Travel & lodging$2,28932%
- Food & beverage$2,35233%
- Education$2714%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 24 | $3,804 |
| Jazz Pharmaceuticals Inc. | 7 | $2,528 |
| Fisher & Paykel Healthcare Inc | 11 | $289 |
| Harmony Biosciences LLC | 10 | $270 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $81 |
| AbbVie | 2 | $48 |
| Lilly USA, LLC | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Noctrix Health, Inc. | 1 | $30 |
| Chiesi USA, Inc. | 1 | $19 |
| Edwards Lifesciences | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$2,423
- XYREM$2,250
- Inspire Upper Airway Stimulation System$1,010
How this compares
$7,161 in reported general payments places this provider in the 85th percentile of 20 sleep medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 75 | $2,384 |
| Modafinil | 30 | $1,419 |
| Gabapentin | 138 | $889 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 46 | $524 |
| Ropinirole Hcl | 12 | $224 |
| Bupropion XlBupropion Hcl | 14 | $167 |
| Trazodone Hcl | 17 | $91 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Oklahoma City
- Viral DoshiOklahoma City$56K
- Cory CrossOklahoma City$3K
- Jared ColvertOklahoma City$1K
- Matthew JohnsonOklahoma City$938
- Christina JacobsOklahoma City$448
- Lucas SittnerOklahoma City$194
- Chee Yoon BauerOklahoma City$47
- Elwood WilliamsOklahoma City$0
- Michael NewnamTulsa$284K
- Jeremy ColeEdmond$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.